Despite the low affinity of S. scabrisporus asparaginase for its substrate, asparagine, under physiological conditions, its stability and efficient glutaminase-free asparaginase activity highlight its potential as a viable alternative for the treatment of ALL. The gene discussed is GLS; the disease is acute lymphoblastic leukemia.